Go offline with the Player FM app!
The New Hit Depression Treatment? A Ketamine-Derived Nasal Spray
Manage episode 472633848 series 2518362
After it was approved in 2019, Spravato, a depression treatment derived from the club drug ketamine, was looking like a dud. But recently it has taken off, and it surpassed $1 billion in annual sales last year for its maker, Johnson and Johnson.
Further Listening:
-A Lawyer Says He Doesn't Need Help for Psychosis. His Family Disagrees.
-America's Maternal Mental Health Crisis
Further Reading:
-J&J’s Ketamine-Derived Drug Is Taking Off
-Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.
Learn more about your ad choices. Visit megaphone.fm/adchoices
1455 episodes
Manage episode 472633848 series 2518362
After it was approved in 2019, Spravato, a depression treatment derived from the club drug ketamine, was looking like a dud. But recently it has taken off, and it surpassed $1 billion in annual sales last year for its maker, Johnson and Johnson.
Further Listening:
-A Lawyer Says He Doesn't Need Help for Psychosis. His Family Disagrees.
-America's Maternal Mental Health Crisis
Further Reading:
-J&J’s Ketamine-Derived Drug Is Taking Off
-Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.
Learn more about your ad choices. Visit megaphone.fm/adchoices
1455 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.